# FDA 483 - Comparative Biosciences, Inc - July 30, 2024

Source: https://www.globalkeysolutions.net/records/483/comparative-biosciences-inc/17ad7641-5177-4b8d-8995-fa0ea23668a8

> FDA 483 for Comparative Biosciences, Inc on July 30, 2024. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Comparative Biosciences, Inc
- Inspection Date: 2024-07-30
- Product Type: other
- Office Name: Division of Human and Animal Food Operations - West V
- Summary: An FDA inspection of Comparative Biosciences, Inc. in Sunnyvale, CA, revealed significant Good Laboratory Practice (GLP) deficiencies. Observations included failures to properly document protocol changes, provide adequate separate laboratory space for BSL-2 studies, and ensure equipment was adequately inspected, cleaned, and maintained with appropriate records. These issues compromise study integrity and biosafety.

## Related Documents

- [483 - 2019-05-17](https://www.globalkeysolutions.net/records/483/comparative-biosciences-inc/a65edc9a-f357-40d5-80bb-3a06625345ec)

## Related Officers

- [Scott N. Lim](https://www.globalkeysolutions.net/people/scott-n-lim/d5e7745a-d804-48d1-8f3b-a94a8d4aed8a)

Company: https://www.globalkeysolutions.net/companies/comparative-biosciences-inc/c0722afa-cde7-48f7-a4d3-630d5c827079

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-v/0f4dd01e-8e8a-4336-9abe-ce8b3d309e8b